SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., a company developing its novel cell therapy platform in late-stage clinical trials in advanced wound care, announced today the appointment of David Crean, ...
The most successful drug or cell therapies are often mechanistically simple and work through a single molecule or cell type. But broadly speaking, when we consider more complex diseases—heart disease, ...
SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc. announced today that it will present at Landmark’s Health Innovations Forum 2022. The invitation-only conference will take place virtually via Zoom on March ...
This graphic illustrates paracrine adhesion signaling on small extracellular vesicles, which secretes a protein called galectin-3, which promotes endocytosis so the vesicle can be absorbed into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results